Compounds > esmolol
Page last updated: 2024-08-24

esmolol and Ventricular Fibrillation

esmolol has been researched along with Ventricular Fibrillation in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.17)18.7374
1990's4 (16.67)18.2507
2000's7 (29.17)29.6817
2010's8 (33.33)24.3611
2020's4 (16.67)2.80

Authors

AuthorsStudies
Frank, M; King, T; Scaturo, N; Shomo, E; Stupca, K1
Li, Y; Tian, AY; Wang, HN; Zhu, D1
Alonso, W; Miguel, LA; Miraglia, D1
Chevillard, L; Grémain, V; Mégarbane, B; Saussereau, E; Schnell, G1
Glaus, T; Meira, C; Ringer, SK1
Li, C; Li, J; Li, Z; Wu, J; Yuan, W; Zhao, Y1
Becker, TK; Gamble, G; Hwang, CW; Marchick, M1
Li, C; Zhang, Q1
Debaty, G; Driver, BE; Plummer, DW; Smith, SW1
Ahn, HC; Cho, GC; Lee, KJ; Lee, WW; Lee, YH; Min, YH; Oh, YT; Park, SM; Park, SO; Seo, JY; Shin, DH; Sohn, YD1
Boehm, KM; Keyes, DC; Mader, LE; Moccia, JM1
Bikias, A; Delithanasis, I; Fragakis, N; Katsaris, G; Konstantinidou, M; Kozirakis, M; Liakopoulos, N1
Dongdong, Z; Guosheng, L; Jingjun, L; Mingwei, B; Yan, Z1
de Oliveira, FC; Feitosa-Filho, GS; Ritt, LE1
Ardell, JL; Dell'Italia, LJ; Ideker, RE; Killingsworth, CR; Kingsley, MA; Smith, WM; Walcott, GP; Wei, CC1
Chiang, CE; Ding, PY; Luk, HN1
Cammarata, G; Huang, L; Sun, S; Tang, W; Wang, J; Weil, MH1
Gazmuri, RJ; Noc, M; Sun, S; Tang, W; Weil, MH; Yang, L1
Fusilli, L; Lee, W; Patel, J; Regan, TJ1
Chow, MS; Colucci, RD; Fan, CD; Kluger, J; Sun, H; Tisdale, JE; Zhao, H1
Bailey, WE; Kosar, EM; Nademanee, K; Rieders, DE; Taylor, R1
Bessho, R; Chambers, DJ1
Biervliet, JD; Koster, RW; van Dantzig, JM1
Euler, DE; Scanlon, PJ; Wallis, DE; Wedel, VA1

Reviews

2 review(s) available for esmolol and Ventricular Fibrillation

ArticleYear
Esmolol in the management of pre-hospital refractory ventricular fibrillation: A systematic review and meta-analysis.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:9

    Topics: Adrenergic beta-1 Receptor Antagonists; Emergency Medical Services; Humans; Propanolamines; Treatment Outcome; Ventricular Fibrillation

2020
Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review.
    Resuscitation, 2012, Volume: 83, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Coronary Circulation; Epinephrine; Heart Arrest; Humans; Myocardium; Oxygen Consumption; Propanolamines; Propranolol; Tachycardia, Ventricular; Vasoconstrictor Agents; Vasopressins; Ventricular Fibrillation

2012

Trials

3 trial(s) available for esmolol and Ventricular Fibrillation

ArticleYear
Comparison of amiodarone and esmolol for prevention of reperfusion ventricular fibrillation in individuals undergoing heart valve or aortic surgery: a study protocol for a randomized controlled clinical trial.
    Trials, 2023, Nov-27, Volume: 24, Issue:1

    Topics: Amiodarone; Heart Valves; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Reperfusion; Ventricular Fibrillation

2023
Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:1

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Synergism; Female; Humans; Male; Middle Aged; Propanolamines; Sulfonamides; Treatment Outcome; Ventricular Fibrillation

2009
Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy.
    Circulation, 2000, Aug-15, Volume: 102, Issue:7

    Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Autonomic Nerve Block; Female; Follow-Up Studies; Humans; Incidence; Life Support Care; Male; Middle Aged; Propanolamines; Propranolol; Prospective Studies; Recurrence; Stellate Ganglion; Time Factors; Ventricular Fibrillation

2000

Other Studies

19 other study(ies) available for esmolol and Ventricular Fibrillation

ArticleYear
Esmolol, vector change, and dose-capped epinephrine for prehospital ventricular fibrillation or pulseless ventricular tachycardia.
    The American journal of emergency medicine, 2023, Volume: 64

    Topics: Cardiopulmonary Resuscitation; Cohort Studies; Emergency Medical Services; Epinephrine; Heart Arrest; Humans; Out-of-Hospital Cardiac Arrest; Retrospective Studies; Tachycardia, Ventricular; Ventricular Fibrillation

2023
Massive suicidal ingestion of caffeine: a case report with investigation of the cardiovascular effect/concentration relationships.
    Clinical toxicology (Philadelphia, Pa.), 2021, Volume: 59, Issue:10

    Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Caffeine; Cardiotoxicity; Central Nervous System Stimulants; Electric Countershock; Half-Life; Heart Rate; Humans; Hyperlactatemia; Infusions, Intravenous; Intubation, Intratracheal; Male; Metabolic Clearance Rate; Middle Aged; Norepinephrine; Powders; Propanolamines; Suicide, Attempted; Tachycardia; Treatment Outcome; Ventricular Fibrillation

2021
Reversal of ventricular fibrillation with esmolol in an anaesthetized cat.
    Veterinary anaesthesia and analgesia, 2018, Volume: 45, Issue:5

    Topics: Adrenergic beta-1 Receptor Antagonists; Anesthesia, General; Animals; Cat Diseases; Cats; Hypertension, Pulmonary; Propanolamines; Ventricular Fibrillation

2018
Selective beta-blocker esmolol improves cerebral cortex microcirculation in a swine ventricular fibrillation model.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:3

    Topics: Animals; Cerebral Cortex; Cerebrovascular Circulation; Male; Microcirculation; Propanolamines; Swine; Ventricular Fibrillation

2019
A case of refractory ventricular fibrillation successfully treated with low-dose esmolol.
    BMJ case reports, 2019, Mar-08, Volume: 12, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Humans; Male; Middle Aged; Propanolamines; Treatment Outcome; Ventricular Fibrillation

2019
Combination of epinephrine with esmolol attenuates post-resuscitation myocardial dysfunction in a porcine model of cardiac arrest.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cardiopulmonary Resuscitation; Drug Combinations; Epinephrine; Heart Arrest; Hemodynamics; Myocardium; Propanolamines; Swine; Ventricular Fibrillation

2013
Use of esmolol after failure of standard cardiopulmonary resuscitation to treat patients with refractory ventricular fibrillation.
    Resuscitation, 2014, Volume: 85, Issue:10

    Topics: Adrenergic beta-1 Receptor Antagonists; Cardiopulmonary Resuscitation; Female; Heart Arrest; Humans; Male; Middle Aged; Propanolamines; Retrospective Studies; Treatment Failure; Ventricular Fibrillation

2014
Refractory ventricular fibrillation treated with esmolol.
    Resuscitation, 2016, Volume: 107

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Cardiopulmonary Resuscitation; Drug Administration Schedule; Drug Monitoring; Drug Resistance; Electric Countershock; Female; Humans; Male; Middle Aged; Neurologic Examination; Out-of-Hospital Cardiac Arrest; Propanolamines; Retrospective Studies; Survival Analysis; Treatment Outcome; Ventricular Fibrillation

2016
First Report of Survival in Refractory Ventricular Fibrillation After Dual-Axis Defibrillation and Esmolol Administration.
    The western journal of emergency medicine, 2016, Volume: 17, Issue:6

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Cardiopulmonary Resuscitation; Electric Countershock; Epinephrine; Heart Arrest; Humans; Propanolamines; Ventricular Fibrillation

2016
Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model.
    Resuscitation, 2009, Volume: 80, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiopulmonary Resuscitation; Disease Models, Animal; Electrocardiography; Heart Ventricles; Male; Phosphorylation; Phosphotransferases; Propanolamines; Ryanodine Receptor Calcium Release Channel; Treatment Outcome; Ventricular Fibrillation; Ventricular Function

2009
Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation.
    Circulation, 2004, May-25, Volume: 109, Issue:20

    Topics: Adrenergic beta-Antagonists; Animals; Combined Modality Therapy; Electric Countershock; Epinephrine; Extracellular Fluid; Heart Ventricles; Kinetics; Myocardial Reperfusion; Myocardium; Norepinephrine; Propanolamines; Survival Analysis; Swine; Ventricular Fibrillation; Ventricular Function, Left

2004
Risk of the use of esmolol in the differential diagnosis of a wide QRS tachycardia.
    International journal of cardiology, 2004, Volume: 97, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Diagnosis, Differential; Humans; Male; Propanolamines; Tachycardia; Ventricular Fibrillation

2004
Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival.
    Critical care medicine, 2004, Volume: 32, Issue:9 Suppl

    Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; In Vitro Techniques; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation

2004
Epinephrine increases the severity of postresuscitation myocardial dysfunction.
    Circulation, 1995, Nov-15, Volume: 92, Issue:10

    Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Drug Therapy, Combination; Electric Countershock; Epinephrine; Myocardial Contraction; Myocardial Reperfusion Injury; Phenylephrine; Propanolamines; Rats; Time Factors; Ventricular Fibrillation

1995
Anti-arrhythmic efficacy of beta-adrenergic blockade during acute ischemia in myocardium with scar.
    The American journal of the medical sciences, 1994, Volume: 307, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Disease Models, Animal; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Propanolamines; Ventricular Fibrillation

1994
Antifibrillatory effect of esmolol alone and in combination with lidocaine.
    Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Drug Therapy, Combination; Heart Rate; Lidocaine; Propanolamines; Swine; Ventricular Fibrillation

1996
Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    The Journal of thoracic and cardiovascular surgery, 2001, Volume: 122, Issue:5

    Topics: Adrenergic beta-Antagonists; Animals; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Constriction; Heart Arrest, Induced; Magnesium; Male; Myocardial Reperfusion Injury; Perfusion; Potassium Chloride; Propanolamines; Rats; Rats, Wistar; Sodium Chloride; Time Factors; Ventricular Fibrillation

2001
Treatment with esmolol of ventricular fibrillation unresponsive to lidocaine and procainamide.
    Journal of cardiothoracic and vascular anesthesia, 1991, Volume: 5, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Humans; Lidocaine; Male; Procainamide; Propanolamines; Ventricular Fibrillation

1991
Effect of esmolol on the ventricular fibrillation threshold.
    Pharmacology, 1988, Volume: 36, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Dogs; Electric Stimulation; Female; Heart Rate; Isoproterenol; Male; Norepinephrine; Propanolamines; Ventricular Fibrillation

1988